- CA$114.11m
- CA$113.94m
- $1.28m
Annual balance sheet for Realbotix, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.98 | 9.74 | 5.84 | 3.49 | 1.44 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | 0.418 | 0.383 | 0.051 | 0.041 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.99 | 40.8 | 6.31 | 3.68 | 1.94 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | — | — | 0.502 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.99 | 43.5 | 20 | 9.87 | 12.2 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.095 | 2.16 | 1.53 | 0.893 | 2.69 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.095 | 21.2 | 5.16 | 0.958 | 4.13 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.89 | 22.4 | 14.9 | 8.91 | 8.07 |
| Total Liabilities & Shareholders' Equity | 4.99 | 43.5 | 20 | 9.87 | 12.2 |
| Total Common Shares Outstanding |